FSD Pharma Responds to Therapix Termination of Binding LOI
December 21, 2018
Ryan Allway December 21st, 2018 FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) in response to Therapix Biosciences’ termination of the company’s binding letter of intent (LOI) to be acquired by FSD Pharma, Dr. Raza Bokhari, Executive Co-Chairman of the Board of FSD... Read more
Gabriella’s Kitchen Adding Seasoned Executives to Its Board
Uncategorized December 20, 2018
Ryan Allway December 20th, 2018 Uncategorized Gabriella’s Kitchen (CSE: GABY) appears to be on the leading edge to service both mainstream grocery and cannabis distribution channels with CBD infused products, as well as CBD and THC-infused edible and wellness products throughout Canada and the U.S. Positioned to be... Read more
Ryan Allway December 20th, 2018 Uncategorized Canada’s cannabis industry may be rapidly growing with new initial public offerings each week, but there has also been a fair share of consolidation within the industry. Investors may want to take a closer look at industry mergers, since they have the... Read more
Canntab & FSD Pharma Make Cannabis More Palatable for Doctors
Uncategorized December 20, 2018
Ryan Allway December 20th, 2018 Uncategorized Cannabinoids have the potential to radically transform the pharmaceutical industry. For example, new studies suggest that cannabis legalization could reduce opioid prescriptions by about six to 12 percent. The problem is that medical cannabis is very different from pharmaceutical drugs—it’s hard for... Read more
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
December 20, 2018
Ryan Allway December 20th, 2018 – 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic– Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced... Read more
High Hampton’s Mojave Jane Announces Start Of Production In California January 2019
December 19, 2018
“While Mojave Jane’s production delivers revenue and cash flow to the Company, it also means realizing the advantages of integrating with High Hampton’s complete portfolio”, commented Gary Latham, High Hampton’s CEO. “That is where the real long term value of this company will be realized.” About Mojave Jane LLC.... Read more
Wiz Khalifa Partners with Supreme to Expand Cannabis Brand
December 18, 2018
Ryan Allway December 18th, 2018 Exclusive, News, Press Releases, Top News The music industry has become increasingly intertwined with the cannabis industry over the past several years. With the partnership between Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Snoop Dogg in 2016, these relationships grew even closer... Read more
Wayland Announces Significant Supply Agreement with RavenQuest BioMed
December 18, 2018
TORONTO, Dec. 18, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) and RavenQuest BioMed Inc. (“RavenQuest”) are pleased to announce the companies have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in... Read more
Biome Grow Receives New Consumer Sales Amendment From Health Canada For Its Nova Scotia brand, Highland Grow.
December 17, 2018
Ryan Allway December 17th, 2018 News, Top News Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets Toronto, Ontario (December 17th, 2018) – Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to... Read more
How California Can Overcome Its Cannabis Challenges
CaliforniaUncategorized December 14, 2018
Ryan Allway December 14th, 2018 Uncategorized California’s cannabis industry is projected to reach $5.1 billion by the end of 2019, according to BDS Analytics, but unexpected challenges have slowed progress. These challenges range from excessive regulations to sky-high taxation. Investors looking for opportunities in the state may want... Read more
